Tompkins Financial’s Lifecore Biomedical LFCR Stock Holding History

Tompkins Financial’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-300	Closed	-$3K	–	434
2019 Q4	$3K	Hold	300	–	–	﹤0.01%	380
2019 Q3	$3K	Hold	300	–	–	﹤0.01%	338
2019 Q2	$3K	Hold	300	–	–	﹤0.01%	341
2019 Q1	$4K	Hold	300	–	–	﹤0.01%	376
2018 Q4	$4K	Hold	300	–	–	﹤0.01%	375
2018 Q3	$4K	Hold	300	–	–	﹤0.01%	390
2018 Q2	$4K	Hold	300	–	–	﹤0.01%	396
2018 Q1	$4K	Hold	300	–	–	﹤0.01%	391
2017 Q4	$4K	Hold	300	–	–	﹤0.01%	355
2017 Q3	$4K	Hold	300	–	–	﹤0.01%	377
2017 Q2	$4K	Hold	300	–	–	﹤0.01%	346
2017 Q1	$4K	Hold	300	–	–	﹤0.01%	338
2016 Q4	$4K	Hold	300	–	–	﹤0.01%	346
2016 Q3	$4K	Hold	300	–	–	﹤0.01%	348
2016 Q2	$3K	Buy	+300	New	+$3.31K	﹤0.01%	479

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Walthausen & Co Malta, New York $120M AUM 2.66% 1-Year Est. Return

Tompkins Financial's LFCR Position: Q1 2020 in Review

Tompkins Financial sold out of Lifecore Biomedical (LFCR) in Q1 2020, closing a stake of 300 shares — an estimated $3K sold.

Tompkins Financial first reported a position in LFCR in Q2 2016 and held it in 15 quarters. The position peaked at $4K in Q1 2019. 88 funds tracked by Wall St. Rank hold LFCR as of Q1 2020.

Tompkins Financial reported no remaining Lifecore Biomedical position as of Q1 2020 after selling out during the quarter.
Tompkins Financial sold 300 Lifecore Biomedical shares in Q1 2020, an estimated $3K.
Tompkins Financial first reported a position in Lifecore Biomedical in Q2 2016 and held it in 15 quarters.
Tompkins Financial's Lifecore Biomedical position peaked at $4K in Q1 2019.
88 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2020.

Based on Tompkins Financial's 13F filing for Q1 2020, filed 22 Apr 2020.